Form 4 for MDT Medtronic
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001127602-21-023107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-02 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | A - Grant | $0.00 | +4,419 | 44.5K | +11% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | F - Tax | $131.31 | -3,908 | 40.1K | -9% | -$513.2K |
| DM | 2021-08-04 | 2021-08-02 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | A - Grant | $0.00 | +49.9K | 37.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-02 | A | A | 4,419 | $0.00 | 44,489 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-02 | F | D | 3,908 | $131.31 | 40,070 | D | — | — | (F2) This balance increased by 245 shares due to exempt transactions such as dividend reinvestment. (F1) This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 1,085 | $0.00 | 1,085 | D | $131.26 · 2022-08-02 to 2031-08-02 | 1,085 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 4 | Derivative | Performance Share Units | 2021-08-02 | A | A | 11,047 | $0.00 | 11,047 | D | — · — to — | 11,047 Performance Share Units | (F6) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 11,047 shares will be issued. The actual number of shares to be issued could range from a low of 2,210 shares at minimum performance to a high of 22,094 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F5) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F7) Vests on August 2, 2024. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 37,754 | $0.00 | 37,754 | D | $131.26 · 2022-08-02 to 2031-08-02 | 37,754 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |